June 24, 2014
GlaxoSmithKline LLC criticized Teva Pharmaceuticals USA Inc.'s request for reconsideration of a Pennsylvania federal judge's refusal to dismiss GSK's suit, which accuses Teva of falsely advertising a generic antidepressant as equivalent to Wellbutrin, arguing Tuesday that Teva misinterpreted Pom Wonderful.
March 10, 2014
A Pennsylvania federal judge refused Monday to dismiss GlaxoSmithKline LLC's lawsuit accusing Teva Pharmaceuticals USA Inc. of falsely advertising a generic antidepressant as equivalent to GSK's brand-name version, saying it was not preempted by a past U.S. Food and Drug Administration finding.
February 11, 2013
GlaxoSmithKline LLC on Friday launched a false advertising suit in Pennsylvania federal court accusing Teva Pharmaceuticals USA Inc. of costing it hundreds of millions of dollars by promoting a generic version of antidepressant Wellbutrin that was discontinued after its effectiveness came into question.